Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting · NCT06430866 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) | Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) | Active, not recruiting | Phase 3 | 2026-04-01 | NCT06430866 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
128 results · Page 1 of 6
Research sites
Swipe the table sideways for more columns.